Skip to content

Comparison of emergence time between sevoflurane alone and short duration desflurane after sevoflurane in general anesthesia patients

Comparison of emergence time between sevoflurane alone and short duration desflurane after sevoflurane in general anesthesia patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0006780
Enrollment
70
Registered
2021-11-25
Start date
2021-12-27
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The planned operation is performed under normal general anesthesia. Both groups use sevoflurane as an inhalation anesthetic during surgery after induction of anesthesia. intergroup arbitration

Sponsors

Kosin University Gospel Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients aged 18-65 years 2) Patients expected to undergo general anesthesia for more than 2 hours during elective surgery 3) Patients corresponding to American Society of Anesthesiologist Status 1-2 ? American Society of Anesthesiologist Status 1: Normal healthy patient ? American Society of Anesthesiology Classification 2: Patients with mild systemic disease (mild systemic disease without functional impairment)

Exclusion criteria

Exclusion criteria: 1) Patients under total intravenous anesthesia 2) Emergency surgery patients 2) body mass index = 30 kg/m2 3) Pregnant and lactating women 4) Patients with lung diseases such as asthma and COPD 5) Patients allergic to drugs (including inhaled anesthetics) a. Patients with a history of hypersensitivity to sevoflurane, desflurane, or other halogenated anesthetics b. Patients with a history of hypersensitivity to remifentanil and other fentanyl analogues c. Patients with a history of hypersensitivity to rocuronium and any of its components or neuromuscular blockers 6) Patients with kidney disease (patients with creatinine clearance less than 60ml/min, patients with renal impairment with a baseline blood creatinine value of 1.5 mg/dL or more) 7) Patients with liver dysfunction 8) Patients with neuromuscular junction disease, including patients with myasthenia gravis and myasthenia gravis 10) Patients who have difficulty in voluntary consent; 11) Patients with a history of psychiatric disorders, including those with difficulty in normal communication 12) Past and family history of malignant hyperthermia 13) Patients with convulsions and patients with acute hepatic porphyria

Design outcomes

Primary

MeasureTime frame
Time required to reach 80 bispectral index after discontinuation of inhaled anesthetic,;Time to open eyes: the time it takes for the patient to open their eyes after stopping the inhaled anesthetic according to a verbal command

Secondary

MeasureTime frame
Time elapsed between discontinuation of inhalation anesthetic and removal of the endotracheal tube;side effects after general anesthesia, such as dizziness, nausea, and vomiting while entering the postanesthesia case unit

Countries

Korea, Republic of

Contacts

Public ContactJu Deok Kim

Kosin University Gospel Hospital

uamyfriends@hanmail.net+82-51-990-6474

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026